Table 4a.
Incidence of histopathologic disease among the 40 women who had no, benign or low-grade histopathologic results at baseline, stratified by high-risk HPV type at baseline
| No histopathologic diagnosis at baseline | Benign histopathologic diagnosis at baseline | CIN1 histopathologic diagnosis at baseline | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| High-risk HPV negative n=17 |
Any High-risk HPV type n=3 |
Any high-risk HPV type n=15 |
HPV 16* n=3 |
HPV 18* n=4 |
Other high-risk HPV type* n=12 |
Any high-risk HPV type n=5 |
HPV 16* n=1 |
HPV 18* n=1 |
Other high-risk HPV type* n=4 |
|
| Benign | 6 | 1 | 6 | 2 | 3 | 5 | 3 | 0 | 0 | 3 |
| CIN1 | 2 | 1 | 2 | 0 | 0 | 2 | 1 | 0 | 1 | 0 |
| CIN2 | 3 | 0 | 3 | 0 | 1 | 2 | 0 | 0 | 0 | 0 |
| CIN3 | 6 | 1 | 4 | 1 | 0 | 3 | 1 | 1 | 0 | 1 |
*
Infection with these types is not mutually exclusive